Skip to main content
SpringerLink
Log in

Effect of clofibrate in non-hemolytic indirect hyperbilirubinemia in full term neonates

  • Original Article
  • Published:
The Indian Journal of Pediatrics Aims and scope Submit manuscript

Abstract

Objective

Jaundice is a common clinical problem in neonatal period which may result in brain damage even in healthy full term newborns, when it is severe. The aim of this study was to characterize the therapeutic effect of clofibrate in full term neonates who present with nonhemolytic jaundice.

Methods

A clinical controlled study was performed on 60 full term neonates who presented with non-hemolytic jaundice. 30 neonates were treated with a single oral dose of clofibrate (100 mg/Kg) plus phototherapy (case group), while 30 neonates received only phototherapy (control group). Both groups were compared in regard to post therapeutic mean total and indirect plasma bilirubin levels, admission duration and the rate of exchange transfusion.

Results

The reduction rate of total and indirect plasma bilirubin levels were significantly higher in the clofibrate-treated group as compared with the control group (P<0.05). The mean duration of admission was found to be reduced from 2.9 +/− 0.9 days in the control groupl to 2.2 +/− 0.6 days in clofibrate-treated group (P=0.002). The mean plasma total bilirubin level was lower in the clofibrate-treated group. No cases required phototherapy after 48 hour in clofibrate-treated group, while 9 neonates (30%) and 2 neonates (6.7%) required phototherapy after 72 hour and 96 hour respectively in the control group. There was no difference between both the groups for sex, the time of developing jaundice and the rate of exchange transfusion.

Conclusion

A single dose of clofibrate (100 mg/Kg) alongwith phototherapy is more effective than phototherapy alone in treating non-hemolytic hyperbilirubinemia in term healthy newborn infants.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Fanaroff AV, Martin RJ. Neonatal-Perinatal Medicine, 8th ed. St. Louis, USA; Elsevier Mosby; Mosby St. Louis, 2006; 1419–1427.

    Google Scholar 

  2. William AH, Ballard RA, Gleason C. Avery’s Diseases of the newborn. 8th ed. 2005: 1226–1256.

  3. Johnson LH, Brown AK, Bhutani VK. System-based approach to management of neonatal jaundice and prevention of kernicterous. J Pediatr 2002; 140: 386–397.

    Google Scholar 

  4. Dennery PA, Seidman D, Stevenson DK. Neonatal Hyperbilirubinemia. NEJM 2001; 344: 581–590.

    Article  PubMed  CAS  Google Scholar 

  5. Dennery PA. Pharmacological intervention for the treatment of neonatal jaundice. Semin Neonatal 2002; 7(2): 111–119.

    Article  Google Scholar 

  6. Carmona MC, Vinaso MT. Activator of peroxisome proliferators-activated receptor-alpha induce the expression of the uncoupling protein-3 gene expression at birth. Diabetes 1999; 48(6): 1272–1222.

    Google Scholar 

  7. Bourget P, Broise I, Desmaris V, Gabilan C. Pharmacokinetics of clofibrate in jaundiced newborn infant at term. Arch Pediatr 1995; 2(8): 722–728.

    Article  PubMed  CAS  Google Scholar 

  8. Gordon B. Avery, Mary Ann Fletcher, Mhairi G. Mac Donald. Neonatology: pathophysiology and management of newborns, 5th ed. Lippincott Williams & Wilkins, 1999: 765–820.

  9. Lindenbaum A, Hernandorena X, Vial M, Benattar C, Janaud JC, Dehan M et al. Clofibrate for the treatment of hyperbilirubinemia in neonates born at term: a double blind controlled study. Arch Fr Pediatr 1981; 38: 867–873.

    PubMed  Google Scholar 

  10. Mohammad-Zadeh A, Farhat AS, Iran-pour R. Effect of clofibrate in jaundiced term newborns. Indian J Pediatr 2005; 72: 123–126.

    Google Scholar 

  11. Gabilan JC. Pharmacologic treatment of neonatal jaundice. A new approach. Arch Pediatr 1998; 5(11): 1274–1278.

    Article  PubMed  CAS  Google Scholar 

  12. Stem L, Khanna NN, Levy G, Yaffe SJ. Effect of phenobarbital on hyperbilirubinemia and glucuronide formation in new borns. Am J Dis Child 1998; 120: 26–31.

    Google Scholar 

  13. Hansen TW. Effect of phenobarbital in bilirubin metabolism rat brain. Biol Neonate 1998; 73: 106–111.

    Article  PubMed  CAS  Google Scholar 

  14. Wong RJ, Stevenson DK. Alternative metaloporphyrins for the treatment of neonatal jaundice. J Perinatol 2001; 21: 108–113.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pediatrics, Hamadan University of Medical Sciences Bessat Hospital, Hamadan, Iran

    Fatemeh Eghbalian, Abolfazl Pourhossein & Hassan Zandevakili

Authors
  1. Fatemeh Eghbalian
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Abolfazl Pourhossein
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Hassan Zandevakili
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Fatemeh Eghbalian.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Eghbalian, F., Pourhossein, A. & Zandevakili, H. Effect of clofibrate in non-hemolytic indirect hyperbilirubinemia in full term neonates. Indian J Pediatr 74, 1003–1006 (2007). https://doi.org/10.1007/s12098-007-0184-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12098-007-0184-x

Key words

Search

Navigation